Treatment-refractory depression: Definitions and characteristics

Depression and Anxiety

Volumn 5, Issue 4, 1997, Pages 154-164

  Berman, Robert M ^a,b,c   Narasimhan, Meera ^a,b   Charney, Dennis S ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Yale University School of Medicine   (United States)

Author keywords

Predictors; Psychosis; Refractory depression; Secondary depression; Unipolar depression

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; CLOMIPRAMINE; DESIPRAMINE; DEXAMETHASONE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; COMORBIDITY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; ELECTROCONVULSIVE THERAPY; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REMISSION; SLEEP; TREATMENT FAILURE;

ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; CASE MANAGEMENT; COMORBIDITY; DEPRESSION; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; ELECTROCONVULSIVE THERAPY; HUMANS; RISK FACTORS; TERMINOLOGY;

EID: 0031408627     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1997)5:4<154::AID-DA2>3.0.CO;2-D     Document Type: Article

References (143)

1. Abou-Saleh M, Coppen A (1983) Classification of depression and response to antidepressive therapies. Br J Psychiatry 143:601-603.
2. Alaskal H (1982) Factors associated with incomplete recovery in primary depressive illness. J Clin Psychiatry 43:266-271.
3. Amsterdam, J (ed): Advances in Neuropsychiatry and Psychopharmacology. Vol. 2. New York: Raven Press Ltd (1991).
4. Amsterdam, J, Brunswick D, Mendels J (1979) High dose desipramine, plasma drug levels and clinical response. J Clin Psychiatry 40:141-173.
5. Armitage R (1995) Microarchitectural finding in sleep EEG in depression: Diagnostic implications. Biol Psychiatry 37:72-84.
6. Ayd F (1983) Treatment-resistant depression. Int Drug 18:25-27.
7. Beckmann H, Goodwin F (1975) Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Arch Gen Psychiatry 32:17-21.
8. Bielski RJ, Fnedel RO (1970) Prediction of tricyclic antidepressant response: A critical review. Arch Gen Psychiatry 33:1479-89.
9. Black D, Winokur G, Nasrallah A (1987) Treatment and outcome in secondary depression: A naturalistic study of 1,087 patients. J Clin Psychiatry 48:438-442.
10. Brockington IF, Heizer JE, Hillier VF, Francis, AF (1982) Definitions of depression: concordance and prediction of outcome. Am J Psychiatry 139:1022-7.
11. Brown R., Frances A, Kocsis J, et al. (1982) Psychotic versus nonpsychotic depression: comparison of treatment response. J Nerv Ment Dis 170:635-637.
12. Brown R, Mason B, Stoll P, et al. (1986) Adrenocortical function and suicidal behavior in depressive disorder. Psychiatry Res 17:313-323.
13. Brown W, Johnson M, Chen M-G ( 1992) Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Res 41:203-214.
14. Brugha T, Bebbington P, MacCarthy B, et al. (1987) Social network, social support and the type of depressive illness. Acta Psychiatr Scand 76:664-673.
15. Brugha TS, Bebbington PE, MacCarthy B, et al. (1990) Gender, social support and recovery from depressive disorders: A prospective clinical study. Psychol Med 20.147-56.
16. Carrol B (1982) The dexamethasone suppression test in melancholia. Br J Psychiatry 140:292-304.
17. Casteneda R, Sussman N, Westreich L, et al. (1996) A review of the effects of moderate alcohol intake on the treatment of anxiety and mood disorders. J Clin Psychiatry 57:207-212.
18. Chan C, Janicak P, Davis J, et al. (1987) Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry 47:197-200.
19. Charney D, Miller H, Licinio J, Salomon R (1994) Treatment of depression. In Nemeroff C (ed): Textbook of Psychopharmacology APA Press, Washington, DC pp 575-602.
20. Charney D, Nelson J (1981) Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry 138:328-353.
21. Clayton (1990) The comorbidity. J Clin Psychiatry 51 (suppl):35-39.
22. Clayton P, Grove (1991) Follow-up and family study of anxious depression. Am J Psychiatry 148:1512-1517.
23. Coble P, Kupfer D, Spider D, Neil JF, McPartland RJ (1979) EEG sleep in primary depression: A longitudinal placebo study. J Affect Disord 1:131-138.
24. Copolov D, Rubin R, Mander R, Sashidharau SP, Whitehouse AM, Blackburn TM, Freeman C, Blackburn IM, Freeman CP, Blackwood DH (1986) DSM-III melancholia: Do the criteria accurately and reliably distinguish endogenous pattern depression? J Affect Disord 10:191-202.
25. Coryell W (1990) DST abnormality as a predictor of course in major depression. J Affect Disord 19:163-9.
26. Coryell W, Tsuang M, McDamel J (1982) Psychotic features in major depression: Is mood congruence important? J Affect Disord 4:227-236.
27. Coryell W, Endicott J, Andreasen N, Keller MB, Clayton PJ, Hirchfield RMA, Scheftner WA, Winaur G (1988) Depression and panic attacks: The significance of overlap as reflected in follow-up and family study data. AmJ Psychiatry 145:293-300.
28. Cramer J Overview of methods to measure and enhance patient compliance. In Cramer J, Spilker B (eds): Patient Compliance in Medical Practice and Clinical Trials. New York: Raven Press, Ltd., 1991.
29. Davidson J, Turnbull C, Strickland R, Belyca M (1984) Comparative diagnostic criteria for melancholia and endogenous depression. Arch Gen Psychiatry 41:506-511.
30. Davidson J, Miller R, Strickland R (1985) Neuroticism and personality disorder in depression. 8:177-182.
31. Davidson JR, Giller EL, Sisook S, et al. (1991) Predictors of response to monoamine oxidase inhibitors: Do they exist? [published erratum appears in Eur Arch Psychiatry Clin Neurosci 1992;241:3761] Eur Arch Psychiatry Clin Neurosci 241:181-6.
32. Epstein L (1984) The direct effects of compliance on health outcome. Health Psychol 4:385-393.
33. Fava M, Davidson K (1996) Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 19.179-200.
34. Fava M, Bouffides E, Pava J, et al. (1994a) Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother Psychosom 62:160-167.
35. Fava M, Roxenbaum J, McGrath P, et al (1994b) Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: A double-blind, controlled study. Am J Psychiatry 151:1372-4.
36. Fawcett J (1983) Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 44:8-11.
37. Fawcett J (1994) Antidepressants: Partial response in chronic depression. Br J Psychiatry 165:37-41.
38. Fawcett J, Maas J, Dekirmenjian H (1972) Depression and MHPG excretion: Response to dextroamphetamine and tricyclic antidepressants. Arch Gen Psychiatry 26:146-251.
39. Filteau M, Baruch P, Lapierre Y, et al. (1995) SSRIs in anxious-agitated depression: A post-hoc analysis of 279 patients. Int Clin Psychopharmacol 10:51-54.
40. Frank E, Perel J, Maliinger A, et al. (1992) Relationship of pharmacologic compliance to long-term prophylaxis in recurrent depression. Psychopharmacol Bull 28:231-235.
41. Frank E, Karp J, Rush A (1993) Efficacy of treatments for major depression. Psychopharmacol Bull 29:457-475.
42. Garvey M, Schaffer C, Tuason V (1984) Comparison of pharmacological treatment response between situational and non-situational depressions. Br J Psychiatry 145:363-365.
43. Garvey M, Hollon SD, DeRubeis RJ, et al. (1990) Does 24-h urinary MHPG predict treatment response to antidepressants? I. A review. J Affect Disord 20:173-9.
44. Garvey M, DeRubeis R, Hollon S, et al. (1991) Response of depression to very high plasma levels of imipramine plus desipramine. Biol Psychiatry 30:57-62.
45. Georgotas A, McCue A (1989) Factors affecting the delay of antidepressant effect in responders to nortripryline and phenelzine. Psychiatry Res 28:1-9.
46. Giles DE, Jarrert RB, Roffwarg HP, et al. (1987) Reduced rapid eye movement latency. A predictor of recurrence in depression. Neuropsychopharmacology 1:33-9.
47. Gillin J, Wyatt R, Fram D, et al. (1978) The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitripyline. Psychopharmacology 59:267-272.
48. Glassman A, Perel J, Shostak, et al. (1977) Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 34:197-204.
49. Grunhaus L, Rabin D, Greden J (1986) Simultaneous panic and depressive disorder: Response to and depressant treatments. J Clin Psychiatry 47:4-7.
50. Grunhaus L, Harel Y, Krugler T, et al. (1988) Major depressive disorder and panic disorder: Effects of comorbidity on treatment outcome with anridepressant medications. Clin Neuropharmacol 11:454-461.
51. Guscott R, Grof P (1991) The clinical meaning of refractory depression: A review for the clinician. Am J Psychiatry 148:695-704.
52. Hall C, Wiles (1990) Compliance with antidepressant medication (Letter) Br J Psychiatry 157:453-454.
53. Hall C, Gardner E, Popkin M, et al. (1981) Unrecognized physical illness prompting psychiatric admission: A prospective study. Am J Psychiatry 138:629-635.
54. Heiligenstein J, Raries D, Rush J, et al. (1994) Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatry Res 52:327-339.
55. Heimann H (1974) Therapy-resistant depressions: Symptoms and syndromes. Contributions to symptomatology and syndromes. Pharmakopsychiatr Neuro psychopharmakol 7:139-44.
56. Hickie I, Parker G (1992) The impact of an uncaring partner on improvement in non-melancholic depression. J Affect Disord 25:147-160.
57. Hirschfeld R, Shea T (1992) Personality. In Paykel (ed): Handbook of Affective Disorders. Churchill Livingstone, New York.
58. Hirschfeld R, Kosier T, Keller M, et al. (1989) The influence of alcoholism on the course of depression. J Affect Disord 16:151-158.
59. Hirschfel RM, Klerman GL, Andreasen NC, et al. (1986) Psychosocial predictors of chronicity in depressed patients. Br J Psychiatry 148:648-54.
60. Hoberman HM, Lewinsohn PM, Tilson M (1988) Group treatment of depression: Individual predictors of outcome. J Consult Clin Psychol 56:393-8.
61. Hoencamp (1994) Predictors of nonresponse in depressed outpatients treated with a three phase sequential medication strategy. J Affect Disord :235-246.
62. Hollister L, Davis K, Berger P (1980) Subtypes of depression based on excretion of MHPG and response to nortriptyline. Arch Gen Psychiatry 37:1107-1110.
63. Horwitz R, Horwitz S (1993) Adherence to treatment and health outcome. Arch Inten Med 153:1863-1868.
64. Ilardi S, Craighead W (1994/5) Personality pathology and response to somatic treatments for major depression: A critical review. Depression 2:200-217.
65. Janicak P, Pandey G, Davis J, et al. (1988) Response of psychotic and nonpsychotic depression to phenelzine. Am J Psychiatry 145:93-95.
66. Joffe RT, Regan JJ (1989) Personality and response to tricyclic antidepressants in depressed patients. J Nerv Ment Dis 177:745-9.
67. Johnson D (1981) Depression: Treatment compliance in general practice. Acta Psychiatr Scand 290 (Suppl):447.
68. Joyce P, Mulder R, Cloninger R (1994) Temperament predicts clomipramine and desipramine response in major depression. J Affect Disord 30:35-46.
69. Joyce PR, Paykel ES (1989) Predictors of drug response in depression [Review]. Arch Gen Psychiatry 46:89-99.
70. Kato T, Inubushi I, Takahashi S (1994) Relationship of lithium concentrations in the brain as measured by lithium-7 magnetic resonance spectroscopy to treatment response in mania. J Clin Psychopharmacol 14:330-335.
71. Keller M (1988) Undertreatment of major depression. Psychopharmacol Bull 24:75-80.
72. Keller M, Lovori P (1988) Commentary: The Adequacy of treating depression. J Nerv Ment Disord 176:471-474.
73. Keller M, Lavori P, Coryell W, et al. (1986) Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 255:3138-3142.
74. Keller MB, Shipiro RW, Lavori PW, et al. (1982) Recovery in major depressive disorder: Analysis with the life table and regression models. Arch Gen Psychiatry 39:905-10.
75. Kelly M, Perry P, Holstad S, et al. (1989) Serum fluoxetine and norfluoxetine concentrations and antidepressant response. Ther Drug Monit 11:165-170.
76. Kendler K, Kessler R, Neale M, et al. (1993) The prediction of major depression in women: Toward an integrated etiologic model. Am J Psychiatry 150:1139-1148.
77. Khan A, Dager S, Cohen S, et al. (1991) Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsychopharmacology 4:125-130.
78. Klerman G, Weissman M, Frank E, et al. Evaluating drug treatments of depressive disorders. In Prien R, Robinson E (eds): Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines. New York: Raven Press, Ltd., 1994.
79. Kocsis J (1990) Predicting treatment response in clinical psychopharmacology. Psychopharmacol Bull 26:49-53.
80. Kotin J, Post R, Goodwin F (1973) Drug treatment of depressed patients referred for hospitalization. Am J Psychiatry 130: 1139-1141.
81. Krauchi K, Wirz-Justice W, Graw P (1993) High intake of sweets late in the day predicts a rapid and persistent response to light therapy in winter depression. Psychiatry Res 46:107-117.
82. Kupfer D (1995) Sleep research in depressive illness: Clinical implications. A tasting menu. Biol Psychiatry 38:391-403
83. Kupfer DJ, Spiker DG (1981) Refractory depression: Prediction of non-response by clinical indicators J Clin Psychiatry 42:307-12.
84. Kupfer DJ, Ehlers CL, Pollock BG, et al (1989) Clomipramine and EEG sleep in depression. Psychiatry Res 30:165-80.
85. Lam D, Green B, Power M, et al (1994) The impact of social cognitive variables on the initial level of depression and recovery. J Affect Disord .75-83.
86. Lam R (1994) Morning light therapy for winter depression: Predictors of response. Acta Psychiatr 89:97-101.
87. Lin H, von Korff M, Katon W, et al. (1995) The role of primary care physicians in patients' adherence to antidepressant therapy. Med Care 33:67-74.
88. Lydiard RB (1985) Tricyclic-resistant depression: Treatment resistance or inadequate treatment? [Review]. J Clin Psychiatry 46:412-7.
89. Maas J, Fawcett J, Dekirmenjian H (1972) Catyecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry 26:252-262.
90. Maas J, Koslow S, Katz M, et al. (1984) Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. AmJ Psychiatry 141:1159-1171.
91. MacEwan G, Remick R (1988) Treatment resistant depression: A clinical perspective. Can J Psychiatry 332:788-792.
92. McGrath P, Stewart J, Harrison W, et al. (1992) Predictive value of symptoms of atypical depression for differential drug treatment outcome. J Clin Psychopharmacol 12:197-202.
93. McLeod J, Kessler R, Landis K (1992) Speed of recovery from major depressive episodes in a community sample of married women. J Abnorm Psychol 101:277-286.
94. Mintz J, Mmtz L, Arruda M, et al. (1992) Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 49:761-768.
95. Mooney J, Schatzberg A, Cole J, et al. (1991) Urinary 3-methosy-4-hydroxphenylglyol and die depression-type score as predictors of differential responses to antidepressants. J Clin Psychopharmacol 11:339-343.
96. Mueller T, Keller M, Leon A, et al. (1996) Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry 53:794-799.
97. Myers E, Calvert E (1984) Information, compliance and side effects: A study of patients on antidepressant medication. Br J Clin Pharmacol 17:21-25.
98. Nelsen M, Dunner D (1993) Treatment resistance in unipolar depression and other disorders: diagnostic concerns and treatment possibilities. Psychiatric Clin North Am 16:541-566.
99. Nelsen M, Dunner D (1995) Clinical and differential diagnostic aspects of treatment-resistant depression. J Psychiatr 29:43-50.
100. Nelson J, Mazure C, Jatlow P (1994) Characteristics of desipramine refractory depression. J Clin Psychiatry 55:12-19.
101. Nierenberg A, Keck PJ, Samson J, et al. (1991) Methodological considerations for the study of treatment-resistant depression. In Amsterdam J (ed): Advances in Neuropsychiatry and Psychopharmacology, Vol. 2. New York: Raven Press, Ltd.
102. Nierenberg A, McLean N, Alpert J, et al. (1995) Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 152:1500-1503.
103. Oren D, Jacobsen F, Wehr T, et al. (1992) Predictors of response to phototherapy in seasonal affective disorder. Compr Psychiatry 33:111-114.
104. Paykel E, Cooper Z (1992) Life events and social stress. In Paykel E (ed): Handbook of Affective Disorders. Churchill Livingstone.
105. Paykel E, Ramana R, Cooper Z, et al. (1995) Residual symptoms after partial remission: An important outcome in depression. Psychol Med 25:1171-1180.
106. Paykel ES, Hollyman JA, Freeling P, et al. (1988) Predictors of therapeutic benefit from amitriptyline in mild depression: A general practice placebo-controlled trial. J Affect Disord 14:83-95.
107. Peselow E, Sanfilipo M, Difiglia C, et al. (1992) Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry 149:1324-1334.
108. Prien R, Carpenter L, Kupfer D (1991) The definition and operational criteria for treatment outcome of major depressive disorder: A review of the current research literature. Arch Gen Psychiatry 48:796-800.
109. Quitkin F (1985) The importance of dosing in prescribing antidepressants. Br J Psychiatry 147:593-597.
110. Quitkin F, Rabkin J, Ross D, et al. (1984) Duration of antidepressant drug treatment: What is an adequate trial? Arch Gen Psychiatry 41:238-245.
111. Quitkin F, Stewart J, McGrath P, et al. (1988) Phenelzine versus imipramine in the treatment of probable atypical depression: Defining syndrome boundaries of selective MAOI responders. AmJ Psychiatry 145:306-311.
112. Quitkin F et al. (1991) Response to phenlzine and imipramine in placebo nonresponders with atypical depression. Arch Gen Psychiatry 48:319-323.
113. Quitken F, McGrath P, Stewart J, et al. (1996) Chronological milestones to guide drug change: When should clinicians switch antidepressants? Arch Gen Psychiatry 53:785-792.
114. Reno R, Halaris A (1990) The relationship between life stress and depression in an endogenous sample. Compr Psychiatry 31:25-33.
115. Ribeiro S, Tandon R, Grunhaus L, et al. (1993) The DST as a predictor of outcome in depression: A meta-analysis. Am J Psychiatry 150:1618-1629.
116. Robbins D, Alessi N (1985) Suicide and the dexamethasone suppression test in adolescence. Biol Psychiatry 20:94-119.
117. Roose S (1994) Selective serotonin reuptake inhibitions in refractory depression. In Nolen W, Zohar F, Roose S, et al. (ed): Refractory Depression: Current Strategies and Future Directions. New York: John Wiley and Sons Ltd.
118. Rush AJ, Roffwarg HP, Giles DE, et al. (1983) Psychobiological predictors of antidepressant drug response, Pharmacopsychiatria 16:192-4.
119. Sachs G (1996) Treatment-resistant bipolar depression. Psychiatr Clin North Am 19:215-236.
120. Schweizer E, Rickels K, Amsterdam J, et al. (1990) What constitutes and adequate antidepressant trial for fluoxetine? J Clin Psychiatry 51:8-11.
121. Scott J (1988( Chronic depression. Br J Psychiatry 153:287-297.
122. Scott J, Eccelston D, Boys R (1992) Can we predict the persistence of depression? Br J Psychiatry 161:633-637.
123. Sharma L, Venkitasubramanian T, Agnihotri B. (1986) 3-MHPG as a non-predictor of antidepressant response to imipramine and electroconvulsive therapy. Acta Psychiatr Scand 74:252-254.
124. Shea M, Glass D, Pildonis P, et al. (1987) Frequency and implications of personality disorder in a sample of depressed patients. J Personality Disord 1:27-44.
125. Sheehan D, Dunbar G, Fuell D (1992) The effect of paroxetine on anxiety and agitation associated with depression. Psychopharmacol Bull 28:139-143.
126. Simpson G, White K, Boyd J, et al. (1982) Relationship between plasma antidepressant levels and clinical outcome from inpatients receiving imipramine. Am J Psychiatry 139:358-366.
127. Sotsky SM, Glass DR, Shea MT, et al. (1991) Patient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH Treatment of Depression Collaborative Research Program. AmJ Psychiatry 148:997-1008.
128. Spiker D, Weiss J, Dealy R, et al. (1985) The pharmacologic treatment of psychotic depression. Am J Psychiatry 142:430-436.
129. Stewart J, Quitkin F, Liebowitz M, et al. (1983) Efficacy of desipramine in depressed outpatients. Arch Gen Psychiatry 40:202-207.
130. Svendsen K, Christensen P (1981) Duration of REM sleep latency as a predictor of effect of antidepressant therapy: A preliminary report. Acta Psychiatr Scand 64:238-243.
131. Targum S, Rosen C, Capodanno A (1983) The dexamethasone suppression test in unipolar depression. Am J Psychiatry 140:877-879.
132. Terman M, Amira L, Terman J, et al. (1996) Predictors of response and nonresponse to light treatment for winter depression. Am J Psychiatry 153:1423-1429.
133. Thase AI, Rush A (1995) Treatment-resistant depression. In Bloom F, Kupfer D (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, Ltd.
134. Tollefson G, Holman S (1994) How long to onset of antidepressant action: A meta-analysis of patients treated with fluoxetine or placebo. Int Clin Pharmacol 9:245-250.
135. Tollefson G, Holman S, Sayler M, et al. (1994) Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features. J Clin Psychiatry 55:50-59.
136. van Valkenberg C, Akiskal H, Puzantian V, et al. (1984) Anxious depression: Clinical family history and naturalistic outcome. J Affect Disord 6:67-82.
137. Voris J, Morin C, Kiel I (1983) monitoring outpatients' plasma antidepressant-drug concentrations as a measure of compliance. Am J Hosp Pharm 40:119-120.
138. Weissman MM, Prusoff BA, Klerman GL (1978) Personality and the prediction of long-term outcome of depression. Am J Psychiatry 135:797-800.
139. West D, Dally P (1959) Effect of Iproniazid in depressive syndromes. Br Med J 1:1491-1494.
140. Wilcox P, Gillan R, Haare E (1965) Do psychiatric patients take their drugs? Br Med J 2:790-792.
141. Worthington J, Fava M, Pollack AI, et al. Consumption of alcohol, nicotine, and caffeine among outpatients with mood and anxiety disorders: Presentation and impact on treatment. Presented at American Psychiatric Association, New York, May 4-9, 1996.
142. Zimmerman M (1987) The Prognostic validity of DSM-III axis IV in depressed inpatients. Am J Psychiatry 144:102-106.
143. Zimmerman M, Pfohl B, Coryell W, et al. (1988) Diagnosing personality disorder in depressed patients: A comparison of patient and informant interviews. Arch Gen Psychiatry 45: 733-737.